Benzaldehyde, which has a positive correlation, inhibits fat formation in normal human liver cells (Li et al., 2021) and reduces the onset of NAFLD, potentially linked to the metabolic product aldehyde oxidase 2. The gene discussed is AOX2P; the disease is metabolic dysfunction-associated steatotic liver disease.